Los Angeles, CA
United States
Division of Hematology and Cellular Therapy
COVID-19, SARS-CoV-2, Cancer, Immune Checkpoint Inhibitors, B-Cell Targeted Therapies, Humoral Immune Response, Breakthrough Infections